Overview


According to FutureWise analysis the market for animal pharmaceutical in 2023 is US$ 48.34 billion, and is expected to reach US$ 92.3 billion by 2031 at a CAGR of 8.42%.

Animal pharmaceuticals, also known as veterinary pharmaceuticals, refer to a category of specialized medications and treatments developed to address the health and well-being of animals. Just as humans require medical interventions to manage various health conditions, animals also need pharmaceutical products tailored to their unique physiological and biological needs. These pharmaceuticals encompass a wide range of products, including vaccines to prevent diseases, antibiotics to treat infections, pain relievers, parasiticides to combat internal and external parasites and hormonal treatments. Animal pharmaceuticals play a crucial role in ensuring the health, productivity, and welfare of livestock, pets, and other animals under human care.

Pharmaceutical interventions play a pivotal role in enhancing longevity and improving the quality of life for animals, addressing various health challenges such as infections, diabetes, obesity, pain management, cancer, and age-related ailments. Just as humans depend on doctors to diagnose ailments and prescribe appropriate therapies, animals rely on skilled veterinarians to adeptly administer a wide spectrum of pharmaceutical treatments. These interventions alleviate suffering and extend the lives of our animal companions, livestock, and other creatures under our care. By harnessing scientific advancements, animal pharmaceuticals can alleviate discomfort, mitigate disease progression, and promote overall well-being. This crucial partnership between veterinary expertise and pharmaceutical innovation contributes to a world where animals can flourish, thrive, and experience an improved standard of living, mirroring the progress achieved in human medicine.

FutureWise Market Research has published a report that provides an insightful analysis animal pharmaceutical market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal pharmaceutical market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base..

  • Zoetis
  • Merck
  • Merial
  • Elanco
  • Bayer Animal Health
  • Boehringer Ingelheim Vetmedica
  • Virbac
  • Ceva Sante Animale
  • Jurox
  • PARNELL

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Animal Pharmaceutical Market:

  • In November 2022-  The company introduced MOVOFLEX, a novel joint supplement for dogs, into the European market.
  • In January 2022- Zoeti received approval from the US FDA for Simparica Trio (chewable tablets containing sarolaner, moxidectin, and pyrantel), featuring a fresh labeling indication aimed at preventing Borrelia burgdorferi infections in dogs.

The increasing prevalence of global demand for animal protein products, driven by population growth and changing dietary preferences, has generated a compelling need for enhanced livestock health and disease management. This demand surge incentivizes investments in advanced pharmaceutical solutions, vaccines, and treatments, fostering innovation and research in animal health to ensure the well-being of livestock populations and the quality of animal-derived products for human consumption. Furthermore, the development and strategic marketing of pharmaceutical products tailored to the unique healthcare needs of companion animals, livestock, and aquaculture species offer an excellent opportunity to grow the animal pharmaceutical market. As consumer awareness of animal health and welfare continues to rise, there is a surging demand for specialized treatments and preventative measures that address specific challenges faced by different animal categories. By capitalizing on this trend, pharmaceutical companies could improve the overall health and productivity of these animals and establish a competitive edge in the market, catering to the diverse and evolving requirements of animal agriculture, pet ownership, and aquaculture industries. Furthermore, the increasing competition from alternative treatment methods and natural remedies faces a constraint in the market's growth. As consumers and animal caregivers increasingly seek non-conventional approaches to healthcare, there is a potential shift away from traditional pharmaceutical solutions. This trend challenges pharmaceutical companies to adapt to changing preferences and demonstrate the efficacy and safety of their products compared to alternative options. Striking a balance between modern pharmaceutical advancements and the appeal of natural remedies poses a significant hurdle in maintaining market share and consumer trust. Moreover, a prominent trend within the animal pharmaceutical industry is the ongoing research and development of novel treatments to address emerging animal diseases. Rapid global interrelation and environmental changes contribute to the emergence of new health threats among animal populations, further driving the growth of the market during the forecast period.
 

By Product Type

  • Vaccine
  • Veterinary Drugs
  • Others

By Application

  • Companion Animal
  • Poultry
  • Others

By Region

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The expansion may be primarily attributed to factors like the rising incidence of zoonotic illnesses and beneficial reimbursement initiatives. For instance, in 2022, Europe emerged as the second-largest market on a regional scale, driven by advantageous governmental directives like the EU Veterinary Medicines Regulation, along with a growing uptake of pet insurance, additionally, by pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. Therefore, the factors mentioned above are expected to dominate the market's growth during the forecast period. 
 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal Pharmaceutical market By Product Type, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data From Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Animal Pharmaceutical Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Animal Pharmaceutical Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Animal Pharmaceutical Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Vaccine
        2. Veterinary Drugs
        3. Others

  • 8.   Global Animal Pharmaceutical Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companion Animal
        2. Poultry
        3. Others

  • 9.   North America Animal Pharmaceutical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million) along with expected regulatory needs
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Europe Animal Pharmaceutical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9.Rest of Western Europe

  • 11.   Asia Pacific Animal Pharmaceutical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million) - along with expected regulatory needs
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 12.   Rest of the World Animal Pharmaceutical Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million) along with expected regulatory needs
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 13.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •   1. Zoetis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merial
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Elanco
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bayer Animal Health
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Boehringer Ingelheim Vetmedica
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Virbac
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ceva Sante Animale
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Jurox
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. PARNELL
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 14.   FutureWise SME key takeaway points for Client
Partner

Our Clients